Skip to main content

Table 4 WHO Trial Registration Data Set (Version 1.3.1). Stockholm Preterm Interaction-Based Intervention

From: Stockholm preterm interaction-based intervention (SPIBI) - study protocol for an RCT of a 12-month parallel-group post-discharge program for extremely preterm infants and their parents

Trial information

Statues of SPIBI

Primary Registry and Trial Identifying Number

Clinical Trials.gov NCT03714633

Date of Registration in Primary Registry

22nd of October 2018

Secondary Identifying Numbers

No protocol number so far. Manual: TiSam – Tidigt Samspel för prematurfödda barn och deras föräldrar: Interventionunderlag

Source (s) of Monetary or Material Support

Stockholm University, Sweden, department of Special Education, through faculty funds.

Karolinska Institutet – department of Women’s and Children’s health, Sweden

Stockholm County Council through the collaboration program with Stockholm University 2017–2019 (SU-SLL no. 20160881)

Centrum för kompetensutveckling inom vård och omsorg at Stockholm University (CKVO) 2018–19 (no. SU FV 2.1.1–402,417)

Clas Groschinskys Minnesfond 2018 (No. SF 18109)

Queen Silvia Jubilee Fund for research on children and disability (date of letter of acceptance 13th of December 2017)

Filénska fonden 2017/2018

K & A Wallenberg foundation (no. SU FV 2..1.9.1894–18)

Lilla Barnets fond (2019-10-01)

Primary Sponsor

Stockholm University

Secondary Sponsor (s)

Karolinska Institutet

Contact for Public Queries

Erika Baraldi, PhD student Stockholm University, erika.baraldi@specped.su.se + 46,812,076,462

Contact for Scientific Queries

PI: Ulrika Ådén, professor of neonatology Karolinska Institutet ulrika.aden@ki.se + 46,852,480,000

Mara Westling Allodi, professor of Special Education Stockholm University mara.allodi@specped.su.se + 468,162,000, + 46,734,612,522

Public Title

Tidigt samspelsbaserad intervention för extremt prematurfödda barn (TiSam)

Scientific Title

Stockholm Preterm Interaction-Based Intervention (SPIBI); RCT of a 12-months parallel-group post-discharge program for extreme premature infants and their parents

Countries of Recruitment

Sweden, Stockholm area

Health Condition (s) or Problem (s) Studied

Extreme prematurity, parenthood of extremely preterm children

Intervention (s)

Active comparator: Home-based post-discharge intervention for extremely premature infants and their parents. The intervention consists of one hospital visit, nine home-visits and two telephone calls during the first year corrected age, specifically from 1 week before discharge to 12 months corrected age. The intervention is strengths-based working with the infant-parent interaction, supporting infant development and strengthening the parent in his/her role.

Control condition: The participants of the Control Group receives treatment as usual, which consists of a regular follow-up program with neurodevelopmental assessment at term age, 3 months corrected age, 12 months corrected age, 24 months corrected age and 66 months corrected age. Compared to children not participating in the study, the control group will receive an extended follow-up program, with assessment and questionnaires at term age, 3 months corrected age, 12 months corrected age, 24 months corrected age and 36 months corrected age. Participants in the control group will be referred to specialized care when needed.

Key Inclusion and Exclusion Criteria

Inclusion Criteria:

• extremely premature born infants 

• close to discharge from their neonatal intensive care unit hospital stay at Stockholm county council (Stockholms Läns Landsting).

Exclusion Criteria:

• Children with parent/parents who do not communicate in Swedish or English.

• Patients not residing in Stockholm County.

• Acute surgery patients who will spend a lot of time at hospitals far from Stockholm

Study Type

Interventional

Study design

Method; randomized

Masking; Semi-masked, primary outcome assessor is blind to allocation

Assignment; Parallel

Purpose; The purpose of the SPIBI is to improve parent-child interaction, child development and parental mental health

Phase; Not fully applicable, Phase II/Phase III

Date of First Enrollment

September 2018

Sample Size

Planned: 130

Today (22nd of November 2019): 48

Recruitment Status

Recruiting

Primary Outcome (s)

Emotional Availability of parent and child measured with Emotional Availability Scales EAS.

Time point: 12 months corrected age

Method: Video Observation of 20 min parent-child interaction, assessed with the manualized method of EAS consisting of 4 parent-specific domains and 2 child-specific domains.

Key Secondary Outcomes

Bayley scales of infant and toddler development third edition, BSID-III

24 months corrected age

Child assessment

Behavior Rating of Executive Function Parental version BRIEF-P

24 and 36 months corrected age

Parent questionnaire of child behavior

Alberta Infant Motor Scale, AIMS

3 and 12 months corrected age

Observation and assessment of child motor development

Hospital anxiety and depression scale, HADS

12, 24 and 36 months corrected age

Parent questionnaire of depressive symptoms

State/trait anxiety inventory, STAI

12, 24 and 36 months corrected age

Parent questionnaire of symptoms of anxiety

Parental self-efficacy scale, PSE

12, 24 and 36 months corrected age

Parent questionnaire of parental self-efficacy

Resilience scale, RES

12, 24 and 36 months corrected age

Parent questionnaire of parental self-efficacy

Ethics Review

SPIBI has been approved by the Regional Ethical Review Board in Stockholm ref. 2017/1596–31.

Date of Approval 26th of October 2019.

Contact: Göran Elinder, scientific secretary, kansli@stockholm.epn.se + 46,852,487,000

Completion date

Last day of recruitment: 31st of August 2020 (anticipated), may be later if target is not reached yet.

Last visit: 31st of August 2021 (anticipated) or 1 year after the ast participant has been recruited.

Data collection completion: 1st of September 2023 (anticipated)

Summary Results

No results yet

IPD sharing statement

Undecided